2019
DOI: 10.1038/s41598-019-46333-2
|View full text |Cite
|
Sign up to set email alerts
|

Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite

Abstract: The anhydrofructose pathway is an alternate pathway for glycogen degradation by α-1,4-glucan lyase. The sugar 1,5-anhydro-D-fructose (1,5-AF) acts as the central intermediate of this pathway, but its physiological role of in mammals is unclear. Glycation reactions forming advanced glycation end-products (AGEs) are important in the development of complications of diabetes mellitus. We hypothesized that 1,5-AF may contribute to cellular damage by forming 1,5-AF-derived AGEs (AF-AGEs) with intracellular proteins.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
37
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(38 citation statements)
references
References 30 publications
1
37
0
Order By: Relevance
“…First of all, AGEs are derived from many different precursor molecules and represent a highly heterogeneous group of compounds ( 253 , 269 ). New variants of AGEs are still being discovered ( 270 ) and it is likely that not all AGE-protein adducts and crosslinks are known in molecular detail. For the analysis of clinical samples, early detection methods took advantage of the fluorescent properties of many AGEs: Collagen from connective tissue was extracted and solubilized by collagenase digestion and fluorescence measured [≈370 nm excitation/440 nm emission ( 271 )].…”
Section: Non-enzymatic Collagen Crosslinking—advanced Glycation Endproductsmentioning
confidence: 99%
“…First of all, AGEs are derived from many different precursor molecules and represent a highly heterogeneous group of compounds ( 253 , 269 ). New variants of AGEs are still being discovered ( 270 ) and it is likely that not all AGE-protein adducts and crosslinks are known in molecular detail. For the analysis of clinical samples, early detection methods took advantage of the fluorescent properties of many AGEs: Collagen from connective tissue was extracted and solubilized by collagenase digestion and fluorescence measured [≈370 nm excitation/440 nm emission ( 271 )].…”
Section: Non-enzymatic Collagen Crosslinking—advanced Glycation Endproductsmentioning
confidence: 99%
“…Products. Advanced glycation end products (AGEs) are produced when reducing sugars do not enzymatically react with the amino groups of proteins and then go through further reactions (including condensation, dehydration, and rearrangement) to turn into irreversibly cross-linked heterogeneous derivatives [133]. Interestingly, in 1912, AGEs were initially identified as Maillard reaction's end products [134].…”
Section: Advanced Glycation Endmentioning
confidence: 99%
“…When purified it had a high substrate specificity for AF, with no detectable activity with glucose, mannose, or fructose [73] indicating that this enzyme is not aldose reductase that reduces glucose to sorbitol. AF is a reactive compound, and its advanced glycation endproducts are detectable in human and animal serum; these compounds accumulate in and are associated with damage to cultured hepatocytes [74].…”
Section: Endogenous Sources Of Af and Agmentioning
confidence: 99%